Original Research
Published on 30 Aug 2024
Single center experience with more than 600 drug desensitization in Colombia
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2024.1460326
- 1,654 views
- 2 citations
Type at least 3 characters
49 articles
Mini Review
Published on 26 Aug 2024
Rare causes of pediatric anaphylaxis due to obscure allergens
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2024.1456100
- 3,045 views
- 1 citation
Original Research
Published on 06 Aug 2024
Drug fever—an immune-mediated delayed type hypersensitivity reaction to Vinca alkaloids in pediatric oncology patients, possibly mediated by cysteinyl leukotrienes
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2024.1361403
- 1,956 views
- 1 citation
Case Report
Published on 11 Mar 2024
Case Report: Mast cell anergy: absence of symptoms after accidental re-exposure to amoxicillin/clavulanic acid 3 days after anaphylaxis
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2024.1366922
- 3,026 views
- 2 citations
Mini Review
Published on 07 Feb 2024
Recent findings on drug hypersensitivity in children
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2024.1330517
- 4,936 views
- 3 citations
Brief Research Report
Published on 16 Jan 2024
Feasibility of a drug allergy registry-based excipient allergy database and call for universal mandatory drug ingredient disclosure: the case of PEG
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2023.1331036
- 2,100 views
- 2 citations
Correction
Published on 12 Jan 2024
Corrigendum: Approach for delabeling beta-lactam allergy in children
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2023.1361973
- 1,504 views
Review
Published on 14 Dec 2023
Potential and limitations of epitope mapping and molecular targeting in Hymenoptera venom allergy
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2023.1327391
- 4,501 views
- 1 citation
Review
Published on 15 Nov 2023
Approach for delabeling beta-lactam allergy in children
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2023.1298335
- 5,146 views
- 8 citations
Editorial
Published on 19 Sep 2023
Editorial: Antibiotic allergy de-labelling and management
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2023.1278690
- 1,756 views
- 1 citation
Brief Research Report
Published on 31 Jul 2023
Use of a beta-lactam graded challenge process for inpatients with self-reported penicillin allergies at an academic medical center
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2023.1161683
- 4,866 views
- 2 citations
Case Report
Published on 27 Jul 2023
Severe exercise-induced anaphylaxis in a hot and humid area successfully treated with omalizumab: a case report
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2023.1228495
- 3,428 views
- 3 citations
Editorial
Published on 13 Jul 2023
Editorial: Assessment and management of adverse drug reactions in oncology
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2023.1223078
- 2,146 views
Original Research
Published on 04 Jul 2023
Multicolor flow cytometry-based immunophenotyping for preclinical characterization of nanotechnology-based formulations: an insight into structure activity relationship and nanoparticle biocompatibility profiles
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2023.1126012
- 3,728 views
- 5 citations
Editorial
Published on 24 May 2023
Editorial: Immune-related adverse Events (irAEs) of biopharmaceuticals
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2023.1214914
- 1,922 views
Editorial
Published on 11 May 2023
Editorial: Diagnosis and management of allergy to chemotherapy and biologics
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2023.1205345
- 3,120 views
- 6 citations